Antimicrobial Peptides: A Promising Solution to the Rising Threat of Antibiotic Resistance
Pharmaceutics · 02.12.2024 · 16 (12) · 1542
DOI: 10.3390/pharmaceutics16121542 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 02.12.2024. Verfasst von Tarequl Islam und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Noakhali Science and Technology University, Sonapur, Noakhali 3814, Bangladesh. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 193 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Prince Sattam Bin Abdulaziz University.
Abstract (Originalsprache)
The demand for developing novel antimicrobial drugs has increased due to the rapid appearance and global spread of antibiotic resistance. Antimicrobial peptides (AMPs) offer distinct advantages over traditional antibiotics, such as broad-range efficacy, a delayed evolution of resistance, and the capacity to enhance human immunity. AMPs are being developed as potential medicines, and current computational and experimental tools aim to facilitate their preclinical and clinical development. Structural and functional constraints as well as a more stringent regulatory framework have impeded clinical translation of AMPs as possible therapeutic agents. Although around four thousand AMPs have been identified so far, there are some limitations of using these AMPs in clinical trials due to their safety in the host and sometimes limitations in the biosynthesis or chemical synthesis of some AMPs. Overcoming these obstacles may help to open a new era of AMPs to combat superbugs without using synthetic antibiotics. This review describes the classification, mechanisms of action and immune modulation, advantages, difficulties, and opportunities of using AMPs against multidrug-resistant pathogens and highlights the need and priorities for creating targeted development strategies that take into account the most cutting-edge tools currently available. It also describes the barriers to using these AMPs in clinical trials.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology, Noakhali Science and Technology University, Sonapur, Noakhali 3814, Bangladesh.
- Department of Pharmacy, Noakhali Science and Technology University, Sonapur, Noakhali 3814, Bangladesh.
- Department of Microbiology, Jagannath University, Dhaka 1100, Bangladesh.
- Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, P.O. Box 173, Al-Kharj 11942, Saudi Arabia.
- Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt.
- Department of Biotechnology, Yeungnam University, Gyeongsan 38541, Gyeongbuk, Republic of Korea.
ORCID-Profile: Tarequl Islam, Md Shahjalal Sagor, Randa Mohammed Zaki, Muhammad Fazle Rabbee, Maximilian Lackner
Förderung
- Prince Sattam Bin Abdulaziz University
Zitieren
APA
Islam, T., Tamanna, N. T., Sagor, M. S., Zaki, R. M., Rabbee, M. F., & Lackner, M. (2024). Antimicrobial Peptides: A Promising Solution to the Rising Threat of Antibiotic Resistance. Pharmaceutics, 16(12), 1542. https://doi.org/10.3390/pharmaceutics16121542
Vancouver
Islam T, Tamanna NT, Sagor MS, Zaki RM, Rabbee MF, Lackner M. Antimicrobial Peptides: A Promising Solution to the Rising Threat of Antibiotic Resistance. Pharmaceutics. 2024;16(12):1542. doi:10.3390/pharmaceutics16121542
BibTeX
@article{Islam2024,
author = {Islam, Tarequl and Tamanna, Noshin Tabassum and Sagor, Md Shahjalal and Zaki, Randa Mohammed and Rabbee, Muhammad Fazle and Lackner, Maximilian},
title = {Antimicrobial Peptides: A Promising Solution to the Rising Threat of Antibiotic Resistance},
journal = {Pharmaceutics},
year = {2024},
volume = {16},
number = {12},
pages = {1542},
doi = {10.3390/pharmaceutics16121542}
}
EUVIMED